Employees: 22
Size Curiox Biosystems (445680.KS) is a South Korea Information Technology company (Packaged Software) with a market value of $551M, the 326th largest of 483 South Korea companies the cockpit tracks. Shares closed at ₩45,700 on 18 Nov 2026.
Performance Over six months the shares fell 51.8%, against -11.4% for the median peer and -37.2% for the South Korea market (cap-weighted) — 2nd lowest of 21 in its peer set.
Growth Revenue grew 37.2% over the last twelve months (peer median -3.0%); the operating margin is -244.1% (peer median -4.9%).
Valuation It trades at 124.3× enterprise value to sales against a peer median of 3.7× (most expensive of 19).
Capital Return on invested capital runs 37.8 points below its cost of capital (8.0% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₩5.84B | ₩5.15B | ₩4.59B | ₩6.79B | ₩7.24B |
| Revenue growth | — | +12% | -32% | -6% | — |
| Gross profit | ₩998M | ₩401M | ₩783M | ₩2.20B | ₩3.31B |
| EBITDA | -₩12.1B | -₩10.1B | -₩11.3B | -₩8.61B | -₩9.82B |
| Net income | -₩15.1B | -₩27.2B | -₩8.09B | -₩10.0B | -₩11.5B |
| Free cash flow | -₩10.6B | -₩11.2B | -₩9.96B | -₩8.38B | -₩10.8B |
| Capital expenditure | ₩64.1M | ₩136M | ₩258M | ₩212M | ₩841M |
| Total debt | ₩517M | ₩2.45B | ₩8.14B | ₩965M | ₩387M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 445680.KS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -15.4% | -8.6% | 7th lowest of 21 |
| 6-month return | -51.8% | -11.4% | 2nd lowest of 21 |
| Distance from 52-week high | -69.4% | -36.0% | 3rd lowest of 21 |
| Revenue growth (TTM) | +37.2% | -3.0% | 3rd highest of 20 |
| Operating margin | -244.1% | -4.9% | lowest of 20 |
| EV / Sales | 124.3× | 3.7× | most expensive of 19 |
| ROIC minus cost of capital | -37.8 pp | -7.6 pp | 2nd lowest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Curiox Biosystems 445680.KS | South Korea | $551M | -52% | +37% | -244% | 124.3× | n/a | n/a |
| GREE Holdings.Inc 3632.T | Japan | $551M | +23% | -11% | 8% | 0.7× | -10.4% | -2.0% |
| Zhejiang TOP Cloud-agri Technology 301556.SZ | China | $551M | -40% | -14% | 13% | 6.7× | 28.0% | +14.0% |
| i3 Verticals IIIV | United States | $553M | +7% | -6% | 2% | 3.6× | n/a | n/a |
| Kaiser (China) Culture 002425.SZ | China | $554M | +22% | -3% | -53% | 6.9× | n/a | n/a |
| Niewiadow Polish Military Group Joint Stock GNS.WA | Poland | $547M | -6% | +490% | -73% | 23.9× | n/a | n/a |
| Seshaasai Technologies STYL.NS | India | $545M | +17% | -2% | 23% | 3.1× | 11.9% | +7.9% |
| Nexxen International NEXN | United States | $545M | +17% | +4% | 6% | 1.1× | 4.6% | +11.5% |
| Horizon Quantum HQ | United States | $544M | -11% | n/a | n/a | n/a | n/a | n/a |
| DBAPPSecurity 688023.SS | China | $563M | -16% | +2% | -5% | 1.6× | 2.9% | +10.3% |
| ENC Digital Technology 603869.SS | China | $538M | -34% | -10% | -8% | 3.9× | n/a | n/a |
| Beijing Deep Glint Technology 688207.SS | China | $564M | -11% | -14% | -195% | 22.3× | n/a | n/a |
| Tanwan 9890.HK | Hong Kong | $567M | -40% | -4% | -6% | n/a | n/a | n/a |
| Sansec Technology 688489.SS | China | $535M | -23% | +18% | -7% | 4.9× | n/a | n/a |
| Shanghai Amarsoft Information & Technology 300380.SZ | China | $569M | -33% | -2% | 4% | 3.4× | n/a | n/a |
| Argo Graphics 7595.T | Japan | $533M | -8% | +8% | 15% | 0.8× | -9.9% | +10.5% |
| Hangzhou Anysoft Information Technology 300571.SZ | China | $533M | -58% | +17% | -11% | 4.9× | n/a | n/a |
| Gresgying Digital Energy Technology 600212.SS | China | $533M | -40% | -8% | -6% | 3.0× | 21.6% | +38.2% |
| PKSHA Technology 3993.T | Japan | $570M | +1% | +78% | 16% | 2.1× | 12.8% | +34.7% |
| Pansoft 300996.SZ | China | $575M | -22% | -4% | 11% | 4.3× | n/a | n/a |
| Heren Health 300550.SZ | China | $528M | -2% | -4% | -11% | 8.1× | 44.0% | -0.9% |